I am former holder, memphian, and wondering what the consensus is here? I know a lot of cash has evaporated over the past several years. Is this maybe a bottom? Just trying to see what is going on.
henry, u got 2 of 3 right, but the American lifestyle does not appreciate the low effectiveness of belviq. Sad fact is, the fast food industry and learned diet of Americans will not allow a pill that does not allow their normal foods. It is hard to beat MuD, taco bell, and pixxa hut, and lots more.
yoda, back in April, I finally figured out that in bio tech, it is like gambling at casino, if you dont quit when you are ahead, u are doomed to lose. So, after a 53% portfolio gain last year, and 12 % ytd in 2014 in late March, a 65% 15 month gain, I sold it all and went to cash. The only way to win in biotech is play the run up, it is like a pyrimid scheme, u got to get in early, then get out with profit and leave the late comers holding the bag. SYN is perfect example, early birds got in at round a buck in Dec., sold at $3 in March, made 200% gain, while latecomers were buying the hype for the news in April, which we all know what happened. I just dont need the stress anymore, I am going strictly low cost index funds, some sector funds, and cash. Oh, I must admit I may buy one bio now and then, got back in ONCS today. Feels good to have a little potential action.
I understand how you folks feel, and if you believe in something, stick with it. But, it does not make sense to me that if they really had something, that insiders would sell. Guess I am jaded after being burned on several bio techs that had similar chart reaction to so called positive news.
Based on Don's rec on another board, I got in at 1.10, back in Dec., the offering and the Kirk investment were incentives for me. I rode up to 3.50, but sold on the way down at $3. At the time, mid to late March, I had had a great ytd return, 20%, while the indexes were flat. In 3 days, my portfolio dropped 8%, so I dumped all and got out with a 12% ytd, and 65% 15 month gain. I have tried to avoid looking at finance stock news, but tonight I looked and say SYN under $1.40, meaning if I held, I would have lost $8,000 on it , and prob. $100,000 on my total, as several other of my previous holdings I now see have dropped huge. What has happened here and bio tech in general? I just saw where Endocyte had dropped from $28 to $6. I am thankful I got out when I did.
with $4 million in revenue? This is another in the long list of biotechs, ie, DNDN, ARIA, HZNP, etc., , in which wise money dumps at the false top, leaving others to hold the bag. Any KERX holders here?
Amazing, what do they have in their "lock box"? I would think if anything worthwhile, big pharma would have bought long ago. Also, I suspect there is a lot of bag holders here, and may be many more on the ride back down. JMO
Do not buy into message board and SA pie in the sky pumpers, Do not keep riding a broken down horse, when a stock with an approved drug that was supposed to be its messiah, during a 4 month bull market for its sector, went south, it is time to wake up and smell the roses. ginny, best of luck to you, but I suggest you become a realist, instead of an idealist, I suspect it may save you money going forward, jmo
Have not posted here in several weeks, about 3 weeks ago, I went basically all cash, did keep ROX, NLST, and SYMX, 3 non biotech spec stocks. Was able to couple last years humongous gains with a 12 % gain for 2014. As I have thought for years, for other than conservative, big cap, dividend paying stocks, the investment in small cap stocks, especially bio techs, is no different than a casino, huge gains in a short while, then, like many people in casinos do, huge losses in a short time. Anyone using normal attributes such as product sales, potential sales, etc. is somewhat clueless in how those markets work. In most small cap drug stocks, the money is made way before any sort of approval is reached. An example, I rode MNKD up from $2 to $8 in 2013, and thankfully got out above $7. After ADCOM approval, it never even reached near the $8.79 of 2013, and now has dropped even more. SYN, a stock I bought last DEC. at $1.10, and avg. at app. $1.60, ran to $3.60 less than a month ago, and is now down about 40% off that price. Nothing has changed in their situation. But, before the max run up, they did say they were announcing results of a crucial trial I think in April. Well, I owned CYTK, which did the same thing last year. Everybody thought, well, the news must be good when they announce the results at the conference, but , guess what, people found loop holds in their results. It appears the bad news has already leaked on SYN, though many are still holding out hope for the news next month. Face it, if the news was going to be great, I imagine plenty folks in the loop would be propping the price up with buys. So, back to ATRS, if the sp was $6 way before approval, and now after approval, it is about half that, what does that tell you? /Among others, the main lesson here is do not fall in love with a stock. Like a few others here who bailed and bought HZNP, INO, SYN, RAD and a few others, the last 15 months proved bountiful. I am pleased to say I am out, GLTA longs.
robert, I am pretty much totally in cash, I had a 20% ytd gain on app. March 20, then a week later, it was down to 12%, so I figured that would be a good year after a great year last year, am happy with a 12% yeat. However, I am still holding SYMX, NLST, and ROX, three spec stocks, still very low priced, and outside the bio tech sector. All 3 have held up well during the Nasdaq/bio tech collapse. I know you commented on them a few weeks ago, do you have any current thoughts? I feel they have very little downside, and expect at least 1, or hopefully 2 to make a nice move up, a double, triple or more this year.
long time bio investor and winner/loser. After being up 20 % ytd, in mid march, dumped all a week later at 11 % gain, thankfully, would otherwise be in red today. From my experience, the best way to make money in bios is to buy when they get sold off due to events, then gradually sell off with profits. HALO is a good example, if you look at 3 year chart, you see numerous big dips, after nice run ups. PRAN is also a good example. glta
It may be for the good, but I bailed on this at $2, and most other spec stocks. But, these offerings can sure beat a person down, especially if they seddenly turn red in their portfolio. Justsaw it on list of losers, glta, it does seem to have a viable future, I am just too tired to continue.
I was in MNKD during the big run of the first half of 2013, and made good, but sold when it started dropping to $6 range. But, with approval pretty much a done deal, I expected $10 or higher. Any thoughts?
investor, I think what is involved here is "ptential". The fact is, the stock prices are often based on going forward, not backward. Maybe that is not sensible, but it is facts. Obviously, TSLA has shown they are a viable company. I see it much like Ford motor co. 100 years ago, but the after effects appear much different. Ford lead to the emergence of big oil, while I understood the Tesla guy to say they would provide free re fueling stations. If they can do this, and bring the price down to a reasonable one, that could destroy the big auto makers and energy companies. I am not surprised that the technology has been there for a while, but am thinking the big oil/auto has squashed it thus far. This TSLA guy is a loose cannon/free spirit that obviously has not caved in. Will be interesting.